3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
4
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Melanoma
7
Endometrial Neoplasms
3
Carcinoma, Hepatocellular
3
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Basal Cell
2
Wilms Tumor
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Nevus, Pigmented
1
Neuroblastoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Mycosis Fungoides
1
Lymphoma, T-Cell, Cutaneous
1
Interventions
pembrolizumab
59
Nivolumab
19
atezolizumab
8
Ipilimumab
8
Docetaxel
7
avelumab
6
Paclitaxel
6
cemiplimab
5
Specimen Handling
5
Cyclophosphamide
5
Biopsy
5
Taxes
4
Pemetrexed
4
Magnetic Resonance Spectroscopy
4
Interleukin-2
4
Gemcitabine
4
Carboplatin
4
utomilumab
3
epacadostat
3
durvalumab
3
Radiotherapy
3
Cisplatin
3
Cetuximab
3
tremelimumab
2
tislelizumab
2
sargramostim
2
poly ICLC
2
obinutuzumab
2
fludarabine
2
enzalutamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
X-Rays
×
Dermatologic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled